Clinical Trial Update: Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial (OXYOP) evaluated HEMO2Life, a marine oxygen carrier, for hypothermic preservation of kidney grafts before transplantation. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• HEMO2Life

Snippet

Sponsor: University Hospital, Brest | Conditions: End Stage Renal Diseases | Phase 1 | Status: COMPLETED